QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 fossil-group-reiterates-fy24-worldwide-net-sales-of-12b

OutlookThe Company is reiterating its full year financial outlook for 2024. Worldwide net sales are expected to be approximatel...

 fossil-group-q2-eps-047-down-from-040-yoy-sales-26000m-down-from-32200m-yoy

Fossil Group (NASDAQ:FOSL) reported quarterly losses of $(0.47) per share. This is a 17.5 percent decrease over losses of $(0.4...

 fossil-group-appoints-andrew-skobe-as-the-companys-interim-cfo-effective-immediately

Fossil Group, Inc. (NASDAQ:FOSL) announced today it has engaged Ankura Consulting Group, LLC to provide interim-CFO services an...

 fossil-group-q1-adj-030-up-from-061-yoy-sales-25490m-down-from-32500m-yoy

Fossil Group (NASDAQ:FOSL) reported quarterly losses of $(0.30) per share. This is a 50.82 percent increase over losses of $(0....

 kanen-wealth-management-sends-letter-to-fossil-group-board

Dear FOSL Directors,Fossil is a $1 bill + co., and a solid brand with ample opportunity, one that enjoys high gross margins in ...

 earnings-scheduled-for-march-13-2024

Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION